Gene expression of baseline biopsies from etrolizumab-treated ulcerative colitis (UC) patients

ABSTRACT: RNA sequencing was performed on RNA isolated from baseline biopsies from UC patients enrolled in the Phase II EUCALYPTUS study of etrolizumab. Gene expression differences were identified in a subset of anti-TNF naïve patients that achieved clinical remission at 10 weeks in response to etrolizumab.

ORGANISM(S): Homo sapiens

PROVIDER: GSE72819 | GEO | 2015/10/26

SECONDARY ACCESSION(S): PRJNA295143

REPOSITORIES: GEO